Clinical Trial Update: A Trial Of Azithromycin SR For The Treatment Of Acute Bronchitis And Secondary Infection Of Chronic Respiratory Diseases [Phase 3]

View source ↗

Summary

Pfizer completed a Phase 3 trial evaluating sustained-release azithromycin for acute bronchitis and related secondary infections in chronic respiratory diseases…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis

Drugs mentioned

• Azithromycin SR (azithromycin)

Snippet

Sponsor: Pfizer | Conditions: Acute Bronchitis | Phase 3 | Status: COMPLETED